Vaxcyte PCVX
NASDAQ PCVX
$56.33 -0.35 (-0.63%)
As of: Sep 30, 2026 · 9:56 AM EDT

Vaxcyte (PCVX) Other Non-Current Assets (2019 - 2026)

Updated

Vaxcyte (PCVX) posted Other Non-Current Assets of $192.56 million for Q2 2026, compared with $1.32 million a year earlier and up 23.8% from the prior quarter.

Analysis

Vaxcyte (PCVX) Other Non-Current Assets (2019 - 2026) Analysis & Trends

At the end of FY2025, Vaxcyte's Other Non-Current Assets came in at $118.85 million, up 84.7% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 193.0% (FY2020 to FY2025).
  • In prior years, Vaxcyte's Other Non-Current Assets was $64.36 million in FY2024, $1.1 million in FY2023 (+26.6%), $871,000 in FY2022 (-78.7%) and $4.09 million in FY2021 (+643.5%).
  • The Q2 2026 figure stands as the highest quarterly Other Non-Current Assets in data going back to Q4 2019.
  • On a year-over-year basis, Other Non-Current Assets increased in three of the last four quarters, with growth averaging 16.3%.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q3 2021, with growth of 710.0%; the weakest was Q4 2022, with a decline of 78.7%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $155.54 million (Q1 2026), $118.85 million (Q4 2025) and $106.71 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 14.27 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.73 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Vaxcyte 8.44 Bn 8.44 Bn - 192.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 192.56 Mn
Mar 31, 2026 155.54 Mn
Dec 31, 2025 118.85 Mn
Sep 30, 2025 106.71 Mn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.32 Mn
Dec 31, 2024 64.36 Mn
Sep 30, 2024 1.32 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 1.10 Mn
Dec 31, 2023 1.10 Mn
Sep 30, 2023 3.19 Mn
Jun 30, 2023 3.48 Mn
Mar 31, 2023 3.94 Mn
Dec 31, 2022 871,000.00
Sep 30, 2022 4.62 Mn
Jun 30, 2022 5.43 Mn
Mar 31, 2022 5.67 Mn
Dec 31, 2021 4.09 Mn
Sep 30, 2021 3.58 Mn
API Access

Vaxcyte Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=PCVX&period=max&api_key=YOUR_API_KEY